Major pharmaceutical companies have agreed to a handful of recommendations aimed at increasing the transparency of clinical trials they fund.
The Nutshell
Daily News Roundup
Most Recent
Exposure to an environmental toxin can affect future generations’ ability to handle stressful conditions.
The FDA approves drugs faster and earlier than regulatory agencies in other countries.
The US Food and Drug Administration has relaxed some of the rules governing how companies must test the sterility of materials used to make biologic drugs.
An examination of Swedish health and educational records suggests that more schooling results in healthier adults.
The FDA is on board with a proposal to speed the approval of experimental pharmaceuticals that show big treatment effects early in clinical testing.
As the human population expands, the number of rare genetic variants has dramatically increased.
The University of Michigan is funding exploratory ideas that cross disciplinary boundaries with $20,000 a pop.
Human-specific duplications of a gene involved in brain development may have contributed to our species’ unique intelligence.
A new bill aims to increase transparency in cancer clinical trials by requiring researchers to divulge all outcomes.
Subjects
- cancer
- cell & molecular biology
- culture
- disease/medicine
- ecology
- evolution
- funding
- genetics & genomics
- NIH
- policy
Sub Categories
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
